Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

Collaborative Guideline Addresses the Perioperative Use of Antirheumatic Drug Therapy

Arthritis & Rheumatology  |  July 25, 2017

A new guideline developed by the ACR and the American Association of Hip and Knee Surgeons addresses the perioperative use of antirheumatic drug therapy. Specifically, it provides recommendations on the use of traditional disease-modifying antirheumatic drugs, biologic agents, tofacitinib and glucocorticoids in adults with RA; SpA, including ankylosing spondylitis and psoriatic arthritis; JIA; or SLE undergoing elective THA or TKA. The guideline provides recommendations regarding when to continue, when to withhold and when to restart these medications, and the optimal perioperative dosing of glucocorticoids…

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis & RheumatologyClinical GuidelineshipkneeResearchsurgerytotal hip arthroplastytotal knee arthroplasty

Drug Tapering: Studies Point to Success in Some Patients

Thomas R. Collins  |  July 17, 2017

Highlights from the 2017 EULAR Congress MADRID—Scores on the Health Assessment Questionnaire for Rheumatoid Arthritis (HAQ) and C-reactive protein (CRP) levels were independent predictors of whether patients could be tapered successfully from a TNF inhibitor after having reached remission of their RA, according to findings presented in a session at the Annual European Congress of…

Filed under:Drug UpdatesMeeting Reports Tagged with:EULAR

2 Biosimilars Make Their Way Toward the European Market

Michele B. Kaufman, PharmD, BCGP  |  July 17, 2017

Two biosimilar treatments, Rixathon and Imraldi, are moving closer to market release in Europe for the treatment of rheumatic and other diseases…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabBiosimilarsEuropean Medicines AgencyPsoriasisrituximabRixathon

Ethics Forum: Facebook Friend Request from Patient Raises Concern for Rheumatologist

Isabelle Amigues, MD, & Paul Sufka, MD, on behalf of the ACR Committee on Ethics & Conflict of Interest  |  July 15, 2017

Social media has revolutionized my practice. I stay current with Twitter content from other rheumatologists, patient organizations and medical journals. I am also an active member of the international Twitter-based rheumatology journal club, #RheumJC. Still, I was recently surprised when my patient’s name appeared in a friend request. This same patient was following me on…

Filed under:Professional TopicsTechnology Tagged with:communicationEthicsFacebookInternetpatientphysicianprivacyrelationshiprequestrheumatologistrheumatologySecuritySocial MediaTwitter

Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA

Lara C. Pullen, PhD  |  July 15, 2017

CHICAGO—Sherine E. Gabriel, MD, MSc, professor of medicine at Rutgers Medical School in Newark, N.J., and a past president of the ACR, presented an overview of cardiovascular disease and rheumatology on a Saturday morning to a room overflowing with rheumatologists attending the ACR’s State-of-the-Art Clinical Symposium in April. She noted that physicians have known for a…

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)cardiovascularmortalitypatient careResearchRheumatic DiseaseRheumatoid arthritisrheumatologyrisk

New Insights & Approvals for Baricitinib

Michele B. Kaufman, PharmD, BCGP  |  July 14, 2017

New research shows that baricitinib is a safe and effective RA treatment. The medication has also been approved for use in Japan and is recommended for use in the U.K…

Filed under:Drug Updates Tagged with:baricitinibEULARJapanOlumiantRheumatoid Arthritis (RA)U.K.

Hepatitis Virus, Rheumatic Disease Connection Explored

Lara C. Pullen, PhD  |  July 14, 2017

CHICAGO—Leonard H. Calabrese, DO, professor of medicine at Cleveland Clinic in Ohio, presented on emerging concepts of viral infections and rheumatic disease at the ACR’s State-of-the-Art Clinical Symposium in April. “We are at a pivotal point in rheumatology in understanding the relationship between viruses and rheumatic disease,” began Dr. Calabrese. “It’s a very exciting time.” Dr. Calabrese…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)comorbiditiesconnectiondirect-acting anti-viralsdrug therapyhepatitisResearchrheumatologysymptomTreatmentVasculitisvirus

Diagnosis, Treatment Updates for Lyme Arthritis

Lara C. Pullen, PhD  |  July 14, 2017

CHICAGO—A clustering of cases in Lyme, Conn., in 1975 led to the discovery of Lyme disease. Allen C. Steere, MD, professor of medicine at Harvard Medical School in Boston, investigated that outbreak, and he shared his knowledge of Lyme disease with rheumatologists gathered at the ACR’s State-of-the-Art Clinical Symposium in April. He explained that Lyme arthritis…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)antibioticsArthritisexposureInfectionLyme Diseasepatient careResearchrheumatologistrheumatologysymptomTreatment

Myositis AutoantibodiesTriggered by Statins

Lara C. Pullen, PhD  |  July 14, 2017

CHICAGO—On a Saturday morning in Chicago, Chester V. Oddis, MD, director of the Myositis Center at the University of Pittsburgh, explained to a crowded room of about 500 rheumatologists attending the ACR’s State-of-the-Art Clinical Symposium in April how best to use myositis autoantibodies in clinical care. He began with an overview of the different types of…

Filed under:ConditionsMeeting ReportsMyositisResearch RheumSoft Tissue Pain Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)dermatomyositisDiagnosismusclemyositisPainpatient carepolymyositisResearchrheumatologistrheumatologyStatinTreatmentweakness

racorn/shutterstock.com

EULAR Releases 2016 Recommendations on RA Management

Mary Beth Nierengarten  |  July 14, 2017

Management of rheumatoid arthritis (RA) is complex. The ever-expanding availability of new drugs requires that rheumatologists and patients constantly consider treatment strategies and targets aimed at both disease control and symptom relief while remaining cognizant of the increasing high cost of emerging medications. Given such complexity, guidelines to inform rheumatologists about the most recent developments…

Filed under:ConditionsEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:drug therapyEULAREuropean League Against RheumatismManagementpatient carerecommendationsRheumatic DiseaseRheumatoid arthritisTreatment

  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 106
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences